Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2010

View Archived Issues

Emory University discloses new subunit-selective NMDA receptor agonists

KPT-127 inhibits tumor growth in vivo in xenograft model

TAK-438 shows promise to treat acid-related diseases

MannKind provides Afrezza for Artificial Pancreas Project

Bayer Schering claims new adenosine A1 receptor agonists

NeuroSearch presents new modulators of nicotinic acetylcholine receptors

Phase IIb data support use of tasocitinib as immunosuppressant in kidney transplant recipients

Roche and Aileron Therapeutics join to develop stapled peptide drugs

FDA clears Prolor Biotech's IND for phase II trial of hGH-CTP

Daiichi Sankyo presents new cyclic amino alcohols for autoimmune conditions

New GlyT-1 inhibitors described by AstraZeneca

New hepatocyte growth factor receptor inhibitors claimed by sanofi-aventis

Raptor Pharmaceuticals provides clinical program update

Isotechnika and 3SBio sign agreement for voclosporin in China

FDA grants fast track status to ThermoDox for HCC

Vyteris to license Georgia Tech's transdermal drug delivery technologies

Cerus regains commercial rights to Intercept blood system from BioOne

Cellonis reports on use of stem cell therapy to treat child with diabetes

Strativa launches Oravig in U.S. for oropharyngeal candidiasis

Human neural stem cell transplants restore function in model of chronic spinal cord injury

Daiichi requests approval to manufacture and market denosumab in Japan

Clinuvel plans pilot trial of Scenesse in vitiligo

Upsher-Smith acquires U.S. marketing rights to Vagifem 10 mcg

Taligen Therapeutics advances TT30 program

Synta Pharma begins phase I trial of STA-9090/docetaxel combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...